Cero Therapeutics Holdings, INC 8-K filings

Phoenix Biotech Acquisition Corp. has amended its merger agreement with CERo Therapeutics, introducing additional earnout shares and modifying vesting conditions.

Phoenix Biotech Acquisition Corp. stockholders voted to approve the merger with CERo Therapeutics, along with related proposals, at a special meeting held on February 8, 2024.

Phoenix Biotech Acquisition Corp. has amended its business combination agreement with CERo Therapeutics, Inc., removing the minimum cash condition and securing a $2 million PIPE financing.